Candosins A-L: potential antiparkinsonian agents from Candolleomyces sp.
Candosins A-L: potential antiparkinsonian agents from Candolleomyces sp.
A plain-language reading has not been prepared for this paper yet.
Original abstract
Three fractions of Candolleomyces sp. cultured on Chinese yam agar solid medium were tested for the neuroprotective activity against Parkinson's disease (PD) induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) with model mice. Assessments including in vivo open field test (OFT), α-synuclein (α-syn) and tyrosine hydroxylase (TH) expression, pathological examination, and in vitro neuroprotective effects revealed that the dichloromethane fraction exhibited anti-PD effect. The work led to the isolation of 12 undescribed guanacastane diterpenoids candosins A-L (1-12). Candosin B (2) was an unprecedented diterpenoid with 6/6/6/5-fused tetracyclic backbone containing one [5.5] spiro ring. Candosins A and C (1 and 3) were undescribed diterpenoid skeletons with 6/6/7/5-fused tetracyclic backbone containing a pyran ring, and a furan ring. The structures were elucidated according to the NMR, HRESIMS, and ECD spectra. Compounds 2-5, 7-9, 11, and 12 exhibited significant neuroprotective effects on MPP + induced PC-12 cell injury, with viability ranging from 68.63% to 87.97%. The docking results indicated that active diterpenoids produced by fungus Candolleomyces sp. might exert a protective effect on PD through α-syn mediated signaling pathway.